静脉-动脉血二氧化碳分压差

Venous-to-Arterial Carbon Dioxide Partial Pressure Difference

摘要

混合静脉血氧饱和度(SvO₂)和中心静脉血氧饱和度(ScvO₂)用于指导休克复苏,但ScvO₂并不能指导改善脓毒症患者预后。静脉-动脉血二氧化碳分压差(ΔPCO₂)被提出可以作为评估复苏效果的重要指标。生理状态下ΔPCO₂约为5~7 mmHg,其升高提示心输出量相对不足,用于指导液体复苏、正性肌力药物滴定,进而评估治疗反应。然而,ΔPCO₂存在局限性:高血流状态下其变化不敏感;脓毒症等炎症状态下微循环障碍可导致其与心输出量关系复杂化;正常ΔPCO₂不能排除局部灌注不足;测量易受技术误差影响。结合其他参数综合解读ΔPCO₂,能够床旁、动态地评估心输出量与代谢需求的匹配程度,有助于实现更精准的个体化复苏目标。

Abstract

Mixed venous oxygen saturation (SvO₂) and central venous oxygen saturation (ScvO₂) are commonly used to guide shock resuscitation. However, ScvO₂ monitoring alone has not been shown to improve outcomes in patients with sepsis. The venous-to-arterial carbon dioxide partial pressure difference (ΔPCO₂) has been proposed as an important indicator for evaluating the adequacy of resuscitation. Under physiological conditions, ΔPCO₂ typically ranges from 5 to 7 mmHg. An increase in ΔPCO₂ indicates a relatively insufficient cardiac output, which can be used to guide fluid resuscitation and titration of inotropic agents, thereby helping to assess the hemodynamic response to therapy. Nevertheless, ΔPCO₂ has limitations: its sensitivity decreases under hyperdynamic circulatory states; in inflammatory conditions such as sepsis, microcirculatory dysfunction can complicate the relationship between ΔPCO₂ and cardiac output; a normal ΔPCO₂ does not exclude regional hypoperfusion; measurement errors may occur due to technical variability. When interpreted in conjunction with other hemodynamic and metabolic parameters, ΔPCO₂ enables bedside and dynamic assessment of the balance between cardiac output and metabolic demand, thereby supporting more precise, individualized resuscitation strategies.

关键词

休克 / 静脉-动脉血二氧化碳分压差 / 组织灌注 / 心输出量 / 氧代谢

Key words

shock / venous-to-arterial carbon dioxide partial pressure difference (ΔPCO₂) / tissue perfusion / cardiac output / oxygen metabolism

参考文献

[1] Miller A, Wilkinson J, Kasal J. Diagnosis of shock states[J]. Crit Care Clin, 2025, 41(3): 397-428.

[2] 朱元州. 血流动力学2024[J]. 巴楚医学, 2024, 7(1): 8-23.

[3] Ltaief Z, Schneider A G, Liaudet L. Pathophysiology and clinical implications of the veno—arterial PCO₂ gap[J]. Crit Care, 2021, 25(1): 318.

[4] Lamia B, Monnet X, Teboul J L. Meaning of arterio—venous PCO₂ difference in circulatory shock[J]. Minerva Anestesiol, 2006, 72(6): 597-604.

[5] Cousin V L, Joye R, Wacker J, et al. Use of CO₂—derived variables in cardiac intensive care unit: pathophysiology and clinical implications[J]. J Cardiovasc Dev Dis, 2023, 10(5): 208.

[6] Said A, Rogers S, Doctor A. Red cell physiology and signaling relevant to the critical care setting[J]. Curr Opin Pediatr, 2015, 27(3): 267-276.

[7] Suresh K, Shimoda L A. Lung circulation[J]. Compr Physiol, 2016, 6(2): 897-943.

[8] Ospina—Tascón G A, Bautista—Rincón D F, Umaña M, et al. Persistently high venous—to—arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock[J]. Crit Care, 2013, 17(6): R294.

[9] Mahutte C K, Jaffe M B, Chen P A, et al. Oxygen Fick and modified carbon dioxide Fick cardiac outputs[J]. Crit Care Med, 1994, 22(1): 86-95.

[10] Diaztagle Fernández J J, Rodríguez Murcia J C, Sprockel Díaz J J. Venous—to—arterial carbon dioxide difference in the resuscitation of patients with severe sepsis and septic shock: a systematic review[J]. Med Intensiva, 2017, 41(7): 401-410.

[11] Adrogué H J, Rashad M N, Gorin A B, et al. Assessing acid—base status in circulatory failure. Differences between arterial and central venous blood[J]. N Engl J Med, 1989, 320(20): 1312-1316.

[12] Chong W H, Saha B K, Medarov B I. Comparing central venous blood gas to arterial blood gas and determining its utility in critically ill patients: narrative review[J]. Anesth Analg, 2021, 133(2): 374-378.

[13] Vallée F, Vallet B, Mathe O, et al. Central venous—to—arterial carbon dioxide difference: an additional target for goal—directed therapy in septic shock[J]. Intensive Care Med, 2008, 34(12): 2218-2225.

[14] van Beest P A, Lont M C, Holman N D, et al. Central venous—arterial pCO2 difference as a tool in resuscitation of septic patients[J]. Intensive Care Med, 2013, 39(6): 1034-1039.

[15] Dubin A, Estenssoro E. Mechanisms of tissue hypercarbia in sepsis[J]. Front Biosci, 2008, 13: 1340-1351.

[16] Groeneveld A B, Vermeij C G, Thijs L G. Arterial and mixed venous blood acid—base balance during hypoperfusion with incremental positive end—expiratory pressure in the pig[J]. Anesth Analg, 1991, 73(5): 576-582.

[17] Zhang H, Vincent J L. Arteriovenous differences in PCO₂ and pH are good indicators of critical hypoperfusion[J]. Am Rev Respir Dis, 1993, 148(4 Pt 1): 867-871.

[18] Van der Linden P, Rausin I, Deltell A, et al. Detection of tissue hypoxia by arteriovenous gradient for PCO₂ and pH in anesthetized dogs during progressive hemorrhage[J]. Anesth Analg, 1995, 80(2): 269-275.

[19] Rackow E C, Astiz M E, Mecher C E, et al. Increased venous—arterial carbon dioxide tension difference during severe sepsis in rats[J]. Crit Care Med, 1994, 22(1): 121-125.

[20] Benjamin E. Venous hypercarbia: a nonspecific marker of hypoperfusion[J]. Crit Care Med, 1994, 22(1): 9-10.

[21] Teboul J L, Mercat A, Lenique F, et al. Value of the venous—arterial PCO₂ gradient to reflect the oxygen supply to demand in humans: effects of dobutamine[J]. Crit Care Med, 1998, 26(6): 1007-1010.

[22] Bakker J, Vincent J L, Gris P, et al. Veno—arterial carbon dioxide gradient in human septic shock[J]. Chest, 1992, 101(2): 509-515.

[23] Vallet B, Teboul J L, Cain S, et al. Venoarterial CO₂ difference during regional ischemic or hypoxic hypoxia[J]. J Appl Physiol (1985), 2000, 89(4): 1317-1321.

[24] Mecher C E, Rackow E C, Astiz M E, et al. Venous hypercarbia associated with severe sepsis and systemic hypoperfusion[J]. Crit Care Med, 1990, 18(6): 585-589.

[25] Wasserman K, Beaver W L, Whipp B J. Gas exchange theory and the lactic acidosis (anaerobic) threshold[J]. Circulation, 1990, 81(1 Suppl): Ⅱ14-Ⅱ30.

[26] Cohen I L, Sheikh F M, Perkins R J, et al. Effect of hemorrhagic shock and reperfusion on the respiratory quotient in swine[J]. Crit Care Med, 1995, 23(3): 545-552.

[27] Dubin A, Murias G, Estenssoro E, et al. End—tidal CO₂ pressure determinants during hemorrhagic shock[J]. Intensive Care Med, 2000, 26(11): 1619-1623.

[28] Ferrara G, Kanoore Edul V S, Martins E, et al. Intestinal and sublingual microcirculation are more severely compromised in hemodilution than in hemorrhage[J]. J Appl Physiol (1985), 2016, 120(10): 1132-1140.

[29] Martikainen T J, Tenhunen J J, Giovannini I, et al. Epinephrine induces tissue perfusion deficit in porcine endotoxin shock: evaluation by regional CO₂ content gradients and lactate—to—pyruvate ratios[J]. Am J Physiol Gastrointest Liver Physiol, 2005, 288 (3): G586-G592.

[30] Ultman J S, Bursztein S. Analysis of error in the determination of respiratory gas exchange at varying FIO₂ [J]. J Appl Physiol Respir Environ Exerc Physiol, 1981, 50(1): 210-216.

[31] Mekontso—Dessap A, Castelain V, Anguel N, et al. Combination of venoarterial PCO₂ difference with arteriovenous O₂ content difference to detect anaerobic metabolism in patients[J]. Intensive Care Med, 2002, 28(3): 272-277.

[32] West J B, Luks A M, Nitin A J. West's Respiratory Physiology: The Essentials, 11th edition[M ]. Netherlands: Wolters Kluwer Health, 2020: 109-111.

[33] Hall J E, Hall M E. Guyton and Hall Textbook of Medical Physiology, 14th edition[M]. USA: Elsevier, 2020: 245-258.

[34] Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal—oriented hemodynamic therapy in critically ill patients. SvO₂ Collaborative Group[J]. N Engl J Med, 1995, 333(16): 1025-1032.

[35] Hayes M A, Timmins A C, Yau E H, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients[J]. N Engl J Med, 1994, 330(24): 1717-1722.

[36] Nassar B, Badr M, Van Grunderbeeck N, et al. Central venous—to—arterial PCO(2) difference as a marker to identify fluid responsiveness in septic shock[J]. Sci Rep, 2021, 11(1): 17256.

[37] Zante B, Reichenspurner H, Kubik M, et al. Increased admission central venous—arterial CO₂ difference predicts ICU—mortality in adult cardiac surgery patients[J]. Heart Lung, 2019, 48(5): 421-427.

[38] Nassar B, Mallat J. Usefulness of venous—to—arterial partial pressure of CO₂ difference to assess oxygen supply to demand adequacy: effects of dobutamine[J]. J Thorac Dis, 2019, 11(Suppl 11): S1574-S1578.

[39] Mari A, Nougue H, Mateo J, et al. Transcutaneous PCO(2) monitoring in critically ill patients: update and perspectives[J]. J Thorac Dis, 2019, 11(Suppl 11): S1558-S1567.

[40] Yuriditsky E, Zhang R S, Bakker J, et al. Relationship between the mixed venous—to—arterial carbon dioxide gradient and the cardiac index in acute pulmonary embolism[J]. Eur Heart J Acute Cardiovasc Care, 2024, 13(6): 493-500.

[41] Denault A, Bélisle S, Babin D, et al. Difficult separation from cardiopulmonary bypass and deltaPCO₂ [J]. Can J Anaesth, 2001, 48(2): 196-199.

[42] Montalti A, Belliato M, Gelsomino S, et al. Continuous monitoring of membrane lung carbon dioxide removal during ECMO: experimental testing of a new volumetric capnometer[J]. Perfusion, 2019, 34(7): 538-543.

[43] Akamatsu T, Inata Y, Tachibana K, et al. Elevated central venous to arterial CO₂ difference is not associated with poor clinical outcomes after cardiac surgery with cardiopulmonary bypass in children[J]. Pediatr Crit Care Med, 2017, 18(9): 859-862.

[44] Felice V B, Araujo D T, Meregalli A F. Value of central venous to arterial CO₂ difference after early goal—directed therapy in septic shock patients[J]. Indian J Crit Care Med, 2019, 23(10): 449-453.

[45] Heino A, Hartikainen J, Merasto M E, et al. Systemic and regional pCO2 gradients as markers of intestinal ischaemia[J]. Intensive Care Med, 1998, 24(6): 599-604.

基金资助

华中科技大学同济医学院护理学院2024年度自主创新基金项目(ZZCX2024L001)